ArticleInternational journal of geriatric psychiatry2022

Potential eligibility for Aducanumab therapy in an Irish specialist cognitive service-Utilising cerebrospinal fluid biomarkers and appropriate use criteria.

Zara Togher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.